Literature DB >> 18615641

Comparative study of the influence of Thy1 deficiency and dietary iron deficiency on dopaminergic profiles in the mouse striatum.

James R Connor1, Xin-Sheng Wang, Elizabeth B Neely, Padmavathi Ponnuru, Hokuto Morita, John Beard.   

Abstract

Thy-1, a glycosyl-phosphatidylinositol (GPI)-linked integral membrane protein, may play a role in stabilizing synapses. Thy1 was identified in a gene expression analysis as iron responsive, and subsequent cell culture and animal models of iron deficiency expanded this finding to the protein. The importance of Thy1 in influencing neurotransmitter feedback mechanisms led to this study to determine the relative effects of Thy1 deficiency and dietary iron deficiency on the dopaminergic system in the mouse striatum. The model for this analysis was the Thy1 null mutant mouse in the presence or absence of dietary iron deficiency. The results revealed significant differences in dopaminergic profiles associated with Thy1 and iron deficiency and also a sex effect. For example, both iron deficiency and the absence of Thy1 are associated with increased dopamine in both sexes, but the dopamine transporter is increased in these experimental groups only in female mice. In male mice, the increase in dopamine transporter is found only in the Thy1 null mutants. Increases in vesicular monoamine transporter and phosphorylated tyrosine hydroxlyase are found only in iron-deficient mice. In contrast decreased release of dopamine from synaptosomes is found only in the Thy1 null mutant animals. In general, these results indicate that a loss of Thy1 can influence the dopaminergic profile in the striatum. Furthermore, the results reveal consistent differences in the dopaminergic profile in Thy1 knockout mice compared with iron-deficient mice, indicating that the effects of iron deficiency are not due only to a change in Thy1 expression. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18615641     DOI: 10.1002/jnr.21758

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Eye-blinking rates are slower in infants with iron-deficiency anemia than in nonanemic iron-deficient or iron-sufficient infants.

Authors:  Betsy Lozoff; Rinat Armony-Sivan; Niko Kaciroti; Yuezhou Jing; Mari Golub; Sandra W Jacobson
Journal:  J Nutr       Date:  2010-03-24       Impact factor: 4.798

Review 2.  Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Authors:  Pan Chen; Omamuyovwi Meashack Ijomone; Kun He Lee; Michael Aschner
Journal:  Adv Pharmacol       Date:  2019-03-14

3.  Gender-specific regulation of tyrosine hydroxylase in thymocyte differentiation antigen-1 knockout mice.

Authors:  N Carkaci-Salli; S Battula; X Wang; J R Connor; K E Vrana
Journal:  J Neurosci Res       Date:  2012-03-19       Impact factor: 4.164

Review 4.  Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction.

Authors:  Betsy Lozoff
Journal:  J Nutr       Date:  2011-02-23       Impact factor: 4.798

Review 5.  Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.

Authors:  Christopher J Earley; George R Uhl; Stefan Clemens; Sergi Ferré
Journal:  Sleep Med       Date:  2016-06-27       Impact factor: 3.492

6.  Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes.

Authors:  Ana M D Carneiro; David C Airey; Brent Thompson; Chong-Bin Zhu; Lu Lu; Elissa J Chesler; Keith M Erikson; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

7.  The iron status of children and youth in a community mental health clinic is lower than that of a national sample.

Authors:  Rhoda J Gottfried; Joan P Gerring; Kyla Machell; Gayane Yenokyan; Mark A Riddle
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03-12       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.